Table S1.
Clinicopathologic variables and ABCC5 protein expression in 180 PCa patients
| Variable | Group | ABCC5 protein expression
|
P-value | ||
|---|---|---|---|---|---|
| n | High | Low | |||
| Age | 0.536 | ||||
| <70 | 97 | 66 | 31 | ||
| ≥70 | 83 | 60 | 23 | ||
| Lymph node metastasis | 0.023 | ||||
| Presence | 17 | 16 | 1 | ||
| Absence | 163 | 110 | 53 | ||
| Surgical margin status | 0.903 | ||||
| Presence | 14 | 10 | 4 | ||
| Absence | 166 | 116 | 50 | ||
| Seminal vesicle invasion | 0.538 | ||||
| Presence | 35 | 23 | 12 | ||
| Absence | 145 | 103 | 42 | ||
| Clinical stage | 0.002 | ||||
| T1 | 103 | 63 | 40 | ||
| T2/T3 | 77 | 63 | 14 | ||
| Preoperative PSA | <0.001 | ||||
| 0–10 | 69 | 38 | 31 | ||
| >10 | 111 | 88 | 23 | ||
| Gleason score | <0.001 | ||||
| <7 | 99 | 49 | 50 | ||
| ≥7 | 81 | 77 | 4 | ||
| Angiolymphatic invasion | 0.837 | ||||
| Presence | 35 | 25 | 10 | ||
| Absence | 145 | 101 | 44 | ||
| Biochemical recurrence | 0.018 | ||||
| Absence | 128 | 83 | 45 | ||
| Presence | 52 | 43 | 9 | ||
Abbreviations: PCa, prostate cancer; PSA, prostate-specific antigen.